Safety and Activity of the Combination of Pegylated Liposomal Doxorubicin and Weekly Docetaxel in Advanced Breast Cancer-Reference-Cited by-同舟云学术

Safety and Activity of the Combination of Pegylated Liposomal Doxorubicin and Weekly Docetaxel in Advanced Breast Cancer

Published:2004-08 Issue:3 Volume:86 Page:249-258
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Morabito Alessandro,Gattuso Domenico,Stani Simonetta Chiara,Fanelli Massimo,Ferraù Francesco,De Sio Livia,Castellana Maria Angela,Lorusso Vito,Priolo Domenico,Vitale Stefano,Sarmiento Roberta,Lo Vullo Salvatore,Mariani Luigi,Gasparini Giampietro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/B:BREA.0000036898.45123.e9

Reference34 articles.

1. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzder AU: Long–term follow–up of patients with complete remission following combination chemoterapy for metastatic breast breast cancer. J Clin Oncol 14: 2197–2205, 1996

2. Valero V, Hortobagyi GN: Are anthracycline–taxane regimens the new standard of care in the treatment of metastatic breast cancer? J Clin Oncol 6: 959–962, 2003

3. Launchbury AP, Habboubi N. Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity. Cancer Treat Rev 19: 197–206, 1993

4. Gasparini G, Dal Fior S, Panizzoni GA, Favretto S, Pozza F: Weekly epirubicin versus doxorubicin as second–line therapy in advanced breast cancer: a randomized clinical trial. Am J Clin Oncol 14: 38–44, 1991

5. Huang L (ed): Covalentely attached polymers and glycans to alter the biodistribution of liposomes. J Liposome Res 2: 289–454, 1992

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive landscape analysis of autophagy in cancer development and drug resistance;Frontiers in Immunology;2024-08-26

2. AKT2 deficiency alleviates doxorubicin-induced cardiac injury via alleviating oxidative stress in cardiomyocytes;The International Journal of Biochemistry & Cell Biology;2024-04

3. Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms;Environmental Research;2023-10

4. Doxorubicin-loaded micelles in tumor cell-specific chemotherapy;Environmental Research;2023-06

5. Protective Effects of Thymoquinone on Doxorubicin-induced Anti/oxidant Levels in Rat Peripheral Tissues;2023-03-24